CaroSpir FDA Approval History
FDA Approved: Yes (First approved August 4, 2017)
Brand name: CaroSpir
Generic name: spironolactone
Dosage form: Oral Suspension
Company: CMP Pharma, Inc.
Treatment for: Heart Failure, Edema, High Blood Pressure
CaroSpir (spironolactone) is an oral suspension formulation of the potassium-sparing diuretic spironolactone indicated for the treatment of heart failure, management of edema, and for use as an add-on therapy in the treatment of hypertension.
Development timeline for CaroSpir
| Date | Article |
|---|---|
| Aug 7, 2017 | Approval CMP Pharma, Inc. Announces FDA Approval of CaroSpir (spironolactone) Oral Suspension |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
